Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy
Gespeichert in:
| Titel: | Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy |
|---|---|
| Autoren: | Elefsiniotis, I. S., Pantazis, K. D., Ketikoglou, I. D., Koutsounas, S. I., Tsianos, E. V. |
| Quelle: | European Journal of Gastroenterology & Hepatology. :1227-1231 |
| Verlagsinformationen: | Ovid Technologies (Wolters Kluwer Health), 2006. |
| Publikationsjahr: | 2006 |
| Schlagwörter: | Adult, Male, 0301 basic medicine, Hepatitis B virus, Genotype, Hepatitis B virus/*immunology, Hepacivirus, Antibodies, Viral, Time, 03 medical and health sciences, Antibodies, Viral/blood, 0302 clinical medicine, Seroepidemiologic Studies, Humans, Hepacivirus/genetics/immunology, Hepatitis B Vaccines, Serologic Tests, Hepatitis B/immunology/*prevention & control, Substance Abuse, Intravenous, Chi-Square Distribution, Greece, Immunization Programs, Substance Abuse, Intravenous/*immunology/virology, Hepatitis C, Chronic/*immunology/virology, Hepatitis C, Chronic, Middle Aged, Hepatitis B, 3. Good health, Female, Hepatitis B Vaccines/*administration & dosage |
| Beschreibung: | To evaluate the serological status of hepatitis B virus infection among Greek injecting drug users with chronic hepatitis C virus infection; to correlate hepatitis B virus infection status with the possible time of infection and the principal genotype of hepatitis C virus infection.Two hundred and thirty consecutive injecting drug users with chronic hepatitis C virus infection were evaluated for serological markers of hepatitis B virus infection. One hundred and three of them (44.8%) reported intravenous drug use beginning before 1992 (group A) and 127/230 (55.2%) after 1992 (group B). Statistical analysis of data was based on Student's t-test and chi analyses.Eighty-five of 103 patients from group A (82.5%) and 28/127 (22%) from group B had serological markers of previous hepatitis B virus infection (P |
| Publikationsart: | Article |
| Sprache: | English |
| ISSN: | 0954-691X |
| DOI: | 10.1097/01.meg.0000236888.51838.36 |
| Zugangs-URL: | https://pubmed.ncbi.nlm.nih.gov/17033445 https://www.ncbi.nlm.nih.gov/pubmed/17033445 https://insights.ovid.com/european-gastroenterology-hepatology/ejghe/2006/11/000/changing-serological-status-low-vaccination/17/00042737 http://olympias.lib.uoi.gr/jspui/handle/123456789/23184 |
| Dokumentencode: | edsair.doi.dedup.....fa3a167f23ec4485539cfd37a9964778 |
| Datenbank: | OpenAIRE |
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstract: | To evaluate the serological status of hepatitis B virus infection among Greek injecting drug users with chronic hepatitis C virus infection; to correlate hepatitis B virus infection status with the possible time of infection and the principal genotype of hepatitis C virus infection.Two hundred and thirty consecutive injecting drug users with chronic hepatitis C virus infection were evaluated for serological markers of hepatitis B virus infection. One hundred and three of them (44.8%) reported intravenous drug use beginning before 1992 (group A) and 127/230 (55.2%) after 1992 (group B). Statistical analysis of data was based on Student's t-test and chi analyses.Eighty-five of 103 patients from group A (82.5%) and 28/127 (22%) from group B had serological markers of previous hepatitis B virus infection (P |
|---|---|
| ISSN: | 0954691X |
| DOI: | 10.1097/01.meg.0000236888.51838.36 |